Filter
1297
Text search:
Vaccine
production
Featured
Recommendations
145
New Publications
320
Language
Document type
No document type
556
Studies & Reports
300
Guidelines
181
Strategic & Response Plan
94
Manuals
74
Fact sheets
43
Training Material
16
Situation Updates
15
Resource Platforms
6
Brochures
4
Infographics
4
Online Courses
2
App
1
Videos
1
Countries / Regions
Global
98
Nigeria
43
India
37
Kenya
37
Sierra Leone
32
Ethiopia
27
Latin America and the Carribbean
27
Africa
27
Liberia
25
Tanzania
24
South Africa
24
Uganda
20
Ghana
19
Nepal
18
Zambia
17
Congo, Democratic Republic of
16
Western and Central Europe
15
Bangladesh
14
Malawi
13
Philippines
12
Syria
12
Rwanda
12
Zimbabwe
11
Pakistan
11
Lesotho
11
West and Central Africa
11
Ukraine
10
Myanmar / Burma
10
Haiti
9
Mozambique
9
Namibia
9
South–East Asia Region
9
South Sudan
8
East and Southern Africa
8
Middle East and North Africa
8
Senegal
7
Sudan
7
Guinea
6
Brazil
6
Afghanistan
5
Germany
5
Cambodia
5
Indonesia
5
Botswana
5
Eswatini/ Swaziland
4
Eastern Europe
4
Mali
3
USA
3
Iraq
3
Jordan
3
Lebanon
3
Thailand
3
Benin
3
Madagascar
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Laos
3
United Kingdom
3
Burkina Faso
2
Saudi Arabia
2
Togo
2
Turkey
2
Egypt
2
Papua New Guinea
2
Libya
2
Sri Lanka
2
Yemen
2
Paraguay
2
Timor Leste/ East Timor
2
Vietnam
2
Cameroon
1
Somalia
1
Chad
1
China
1
Central African Republic
1
Argentina
1
Peru
1
North Macedonia
1
Burundi
1
Colombia
1
Bolivia
1
Chile
1
Other region
1
Palestine
1
Djibouti
1
Tajikistan
1
Russia
1
Qatar
1
Moldova
1
Iran
1
Georgia
1
Turkmenistan
1
France
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
481
Clinical Guidelines
132
Public Health
67
Key Resources
57
Women & Child Health
53
Pharmacy & Technologies
21
Capacity Building
6
Toolboxes
COVID-19
221
AMR
62
TB
60
NTDs
58
Rapid Response
46
Health Financing Toolbox
46
HIV
45
Ebola & Marburg
44
Planetary Health
43
Global Health Education
30
Conflict
29
2.0 Rapid Response
27
Pharmacy
25
Cholera
23
Polio
20
Malaria
18
Natural Hazards
17
Caregiver
14
Refugee
12
Mental Health
11
NCDs
10
Disability
7
Specific Hazards
6
Zika
4
South Sudan
1
Lancet Glob Health 2016; 4: e856–63. Open Access
The article "Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study" investigates whether a single dose of the Shanchol oral cholera
...
September 2021
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a
...
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in
...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in ch
...
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication st
...
Interim Guidance, published 11 January 2021.
The cold chain is necessary to prevent damage to vaccines caused by heat exposure. However, improper use of cold chain equipment may cause damage to freeze-sensitive vaccines (i.e. those vaccines containing alum adjuvant or oil-emulsion adjuvant). Studie
...
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vacc
...
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
The document will provide information for Ministries of Health and hospital sentinel sites on why and how to determine the denominator of at-risk children <5 years of age and rate of meningitis hospitalizations for a sentinel hospital site conducting IB-VPD surveillance. Such a methodology is currently unavailable and this estimation is critical to enable interpretation of surveillance data, particularly pre- and post-
...
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a
...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i
...
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br
...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a
...
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
